Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 27, 2026

Dow confirms correction as traders worry about war

View original at sg.finance.yahoo.com
Dow confirms correction as traders worry about war By Noel Randewich March 27 (Reuters) - The Dow Jones Industrial Average fell 1.7% on Friday as investors worried about the global economic ‌impact of the war in Iran, leaving the blue-chip index down ‌10% from its record high close on February 10 and confirming it has…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Investors are weighing whether the downturn is a temporary dip similar to the recovery that followed the 2025 selloff, or the start of a sustained period of risk tied to the war

    60% confidence
  • The Dow Jones Industrial Average has confirmed it has been in a correction since its record high close on February 10, now down 10% from that level

    60% confidence
  • Sky-high oil prices have sparked fears of inflation, with traders expecting the Federal Reserve to be more likely to raise interest rates by year-end than cut rates

    60% confidence

Data points we hold from this source

Dow Jones Industrial Average · drawdown from peak-10 percent
Dow Jones Industrial Average · decline since iran war-7 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Dow confirms correction as traders worry about war — Source | Via News | ViaNews Market